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OBJECTIVES We sought to determine the incidence and causes of geographical miss (GM) and to evaluate
its impact on edge restenosis after intracoronary beta-radiation therapy.
BACKGROUND Edge restenosis is a limitation of intracoronary beta-radiation therapy. Geographical miss is
the situation in which the radiation source does not fully cover the injured segment and may
lead to edge restenosis.
METHODS We analyzed 175 vessels treated according to the Beta-Radiation In Europe (BRIE) study
protocol. The effective irradiated segment (EIRS) and both edges were studied with
quantitative coronary angiography. The edges of the EIRS that were injured constituted the
GM edges. Restenosis was defined as diameter stenosis .50% at follow-up. Geographical
miss was determined by simultaneous electrocardiographic-matched, side-by-side projection
of the source and balloons deflated at the injury site, in identical angiographic projections
surrounded by contrast.
RESULTS Geographical miss affected 41.2% of the edges and increased edge restenosis significantly
compared with non-GM edges (16.3% vs. 4.3%, respectively, p 5 0.004). Restenosis was
increased both in the proximal (p 5 0.05) and distal (p 5 0.02) GM edges compared with
noninjured edges. Geographical miss associated with stent injury significantly increased edge
restenosis (p 5 0.006), whereas GM related to balloon injury did not significantly increase
edge restenosis (p 5 0.35). The restenosis in the EIRS was similar between vessels with and
without GM (24.3% and 21.6%, respectively, p 5 0.8).
CONCLUSIONS Geographical miss is strongly associated with restenosis at the edges of the EIRS. This effect
is more prominent when caused by stenting. Geographical miss does not increase restenosis
in the EIRS. (J Am Coll Cardiol 2001;38:415–20) © 2001 by the American College of
Cardiology
Intracoronary radiation therapy is a new technique for the
prevention of restenosis after percutaneous coronary inter-
ventions (1–3). Catheter-based systems and radioactive
stents are currently used to deliver radiation (4). The
development of stenotic lesions at the edges of the segment
receiving the full-prescribed dose is a potential limitation of
this treatment. This phenomenon described both after
radioactive stent implantation and catheter-based intracoro-
nary radiation was termed the “edge effect” (5–7). The
pathophysiology of the “edge effect” may be the result of
vessel wall injury (8–10) concomitant with low-dose radia-
tion at the edges of the irradiated segment (11,12). The
term geographical miss (GM) was invented in radio-
oncology to define a cause of treatment failure due to low
dose radiation. In such cases, a small part of the treatment
zone either escaped radiation or was inadequately irradiated
because the total volume of the tumor was not appreciated
and hence an insufficient margin was taken (13). This
concept was translated in interventional cardiology to define
those coronary segments that were injured but received
low-dose radiation (14). Aims of the study were to deter-
mine the incidence and causes of GM and to evaluate the
impact of this inadequate treatment on the angiographic
outcome in vessels treated according to the protocol of a
multicenter intracoronary beta-radiation study using a
catheter-based system.
METHODS
Patient selection. We retrospectively analyzed 149 pa-
tients treated with catheter-based beta-radiation using the
Beta-Cath system (Novoste Corp., Norcross, Georgia) en-
rolled in the Beta-Radiation In Europe (BRIE) trial.
Patients included in the radiation protocol were those with
objective signs of ischemia and presence of significant de
novo lesions. Out of the total population, 123 patients
underwent single-vessel percutaneous transluminal coronary
angioplasty and the remaining 26 patients underwent two-
vessel angioplasty, giving 175 vessels in total. In 36 patients
(44 vessels) GM was not interpretable, leaving 113 patients
with 131 vessels for further analysis. Characteristics of
patients with interpretable angiographic documentation are
summarized in Table 1.
From the *Department of Cardiology, Thoraxcenter, Erasmus Medical Center
Rotterdam, Rotterdam, Netherlands, and †Cardialysis BV, Rotterdam, Netherlands.
Manuscript received August 11, 2000; revised manuscript received March 29, 2001,
accepted April 10, 2001.
Journal of the American College of Cardiology Vol. 38, No. 2, 2001
© 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00
Published by Elsevier Science Inc. PII S0735-1097(01)01381-X
Device description. The device consists of three compo-
nents: 1) the transfer device, which stores the radiation
source train and allows its positioning within the catheter;
2) the delivery catheter, which is a 5 Fr multilumen
noncentered catheter that uses saline to send and return the
radiation source train; and 3) the radiation source train,
consisting of 12 independent cylindrical seeds that contain
the radioisotope 90Sr/90Y source, encompassed by two
radiopaque gold markers (30 mm in length) (4). The
longitudinal distance of the “full” prescribed dose (100%
isodose) coverage measured by radiochromic film is about
26 mm (15), constituting the effective irradiation length.
Dosimetry. Prescribed dose at 2 mm from the centerline of
the source axis was 14 to 18 Gray (Gy), based on the
reference diameter, by on-line quantitative coronary angiog-
raphy (QCA), measured ,3.35 mm or .3.35 mm, respec-
tively. The radiation source remained at the treatment site
for approximately 2 to 4 min to deliver the prescribed dose.
Post-hoc QCA confirmed appropriate dosimetry in all
treated vessels.
Definitions. Vessel segment (VS) defined the coronary
segment bordered by two side branches that encompassed
the original lesion, angioplasty balloon and radiation source.
The injured segment (INS) was encompassed by the most
proximal and distal position of the radiopaque markers of
the balloons used for dilation or stent implantation. The
irradiated segment, 30-mm in length, was defined as the
segment encompassed by the two gold markers of the
radiation source train. The effective irradiated segment
(EIRS) was the segment that received the full-prescribed
dose and corresponded to the 26-mm central part of the
radioactive source train. These segments are illustrated in
Figure 1. The edges of the EIRS are the adjacent (proximal
and distal) 5 mm coronary segments, consisting of the 2 mm
inside and 3 mm outside the gold markers. These edges
received low-dose radiation because of fall-off of dose in the
beta-emitting 90Sr/90Y source (16,17). The highest pre-
scribed dose was 18 Gy at 2 mm from the centerline of the
source axis and the calculated dose at each millimeter away
from the 100% isodose in the axial direction was expected to
be 15.5 Gy at 1 mm, 11 Gy at 2 mm, 5.5 Gy at 3 mm, 2.4
Gy at 4 mm and ,1 Gy at 5 mm (Fig. 1). Those edges,
which were traumatized by balloon inflation (minimum
inflation pressure was 6 atmospheres) or received new stent
implantation during the procedure, were defined as GM
edges. Noninjured edges were those that were not trauma-
tized during the intervention.
Determination of the GM edges. To determine whether
the edges of the EIRS were injured, we retrospectively
analyzed, blind to the presence or absence of restenosis and
its location at follow-up, all the baseline (intervention plus
radiation) angiograms. The following steps were followed:
during the procedure all the interventions (balloons or
stents) deflated at the site of injury and the radioactive
source in place were filmed with contrast in identical
angiographic projections. This approach allowed us to
define the location of the various subsegments (EIRS, INS
and edges) in relation to side branches and the correct
matching of the angiograms in the offline analysis. A
continuous electrocardiogram recording was also dis-
played, allowing the selection of still frames in the same part
of the cardiac cycle. Multiple angiographic loops and
electrocardiographic-matched still frames could be dis-
played simultaneously, side by side, on the screen with the
Rubo DICOM Viewer (Rubo Medical Imaging, Uithoorn,
Netherlands). By identifying the relationship between the
EIRS and its edges relative to the INS, we determined the
GM edges. Two independent cardiologists (G.S., M.C.)
performed the above-mentioned analysis. There was only
10% disagreement on the presence or absence of GM and its
location proximal or distal. These were borderline cases that
were reanalyzed by a third reviewer (P.W.S.) with the use of
transparencies before a final conclusion was determined.
In cases where one or more of the following criteria were
present, the procedure was reported as noninterpretable: 1)
incorrect filming of the radiation source or the balloons
deflated with contrast injection; 2) more than 10° difference
in the angiographic projections not allowing correct match-
ing; and 3) interventions reported in the technician’s work
sheet but not filmed.
QCA analysis. The EIRS and both edges were analyzed by
QCA before and after intervention, and at six-month
follow-up. All angiograms were evaluated after intracoro-
nary administration of nitrates. The offline analysis of two
Abbreviations and Acronyms
BE 5 balloon edges
BRIE 5 Beta-Radiation In Europe study
CI 5 confidence interval
EIRS 5 effective irradiated segment
GM 5 geographical miss
Gy 5 Gray
INS 5 injured segment
IVUS 5 intravascular ultrasound
OR 5 odds ratio
QCA 5 quantitative coronary angiography
SE 5 stent edges
VS 5 vessel segment
Table 1. Patients and Procedural Characteristics




Prior MI 39/113 (34.5%)




Balloon angioplasty 48/131 (36.6%)
Rescue stenting 12/131 (9.2%)
Provisional stenting 71/131 (54.2%)
CABG 5 coronary artery bypass graft operation; LAD 5 left anterior descending;
LCX 5 left circumflex; MI 5 myocardial infarction; RCA 5 right coronary artery.
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orthogonal projections was performed with the CAAS II
analysis system (Pie Medical BV, Maastricht, Netherlands).
Calibration of the system was based on dimensions of the
catheters not filled with contrast. This method of analysis
has been previously validated (18–20). The following QCA
parameters were computed in the VS: computer-defined
minimal luminal diameter, reference diameter obtained by
an interpolated method and percentage diameter stenosis.
Binary restenosis was defined in every segment as diameter
stenosis .50% at follow-up. This allowed the determina-
tion of restenosis in the VS (overall restenosis). Computer-
defined subsegmental analysis (mean subsegment length
was 5 6 0.3 mm, depending on the length of the analyzed
VS) was also performed. In each subsegment, percentage
diameter stenosis was also automatically calculated. This
allowed the determination of restenosis in relation to the
dose-based subsegments, which was termed regional resten-
osis.
Determination of the restenosis location. Three observ-
ers analyzed all the films that appeared to have restenosis at
the follow-up angiogram. The printouts of the pre-, post-
and follow-up angiograms, in two orthogonal projections,
with the subsegmental analysis and the dose-based subseg-
ments superimposed, were compared. The observers desig-
nated the location of the computer-defined QCA subseg-
ments with restenosis in relation to the dose-based
segments. Restenosis was classified as restenosis in the
EIRS, edge restenosis (proximal or distal) and restenosis
outside the irradiated segment. It is important to realize that
the criterion for binary restenosis might be fulfilled in more
than one subsegment in the same VS.
Statistical analysis. Continuous data are presented as
mean values; discontinuous data are presented as percent-
ages. Differences in restenosis rates between edges with and
without GM were evaluated with chi-square or Fisher exact
tests as appropriate. Because the behavior of different
Figure 1. (Left) Isodose contour rate map and radiation source train. Isodose rate contour map at a depth of 1.89 mm (10 mGy/s contour intervals) as
described by National Institute of Standards and Technology. This depth (1.89 mm) illustrates an isodose model resembling the radius of the coronary artery
wall. The longitudinal dose falloff may be extrapolated from this graphic. The central part of the source train (26 mm) radiates approximately full dose
constituting the effective irradiation length (EIRL). (Right) A diagram of an irradiated coronary artery and the anatomical and dose-based segment
definition. EIRS 5 effective irradiated segment; INS 5 injured segment; IRS 5 irradiated segment; IRL 5 irradiation length; SB 5 side branch; VS 5
vessel segment.
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segments in the same vessel and the behavior of different
vessels in the same patient may not be independent, the
relation between GM and edge restenosis was further analyzed
by logistic regression analysis, using generalized estimation
equation modeling techniques to correct for possible within-
patient effects. The presented odds ratios (OR) and 95%
confidence intervals (CI) are based on these analyses. Statistical
significance of all tests was defined at the p , 0.05 level.
RESULTS
Incidence and causes of GM. VESSELS. A total of 131
vessels were interpretable. The incidence of GM was 67.9%
(Table 2).
EDGES. In each vessel, both proximal and distal edges of the
EIRS were analyzed, giving in total 262 edges. Out of the 89
vessels with GM, 70 had one GM edge, proximal or distal, and
in 19 vessels both edges were injured, giving in total 108 GM
edges. The incidence of GM at the edges was 41.2%. The
location proximal and distal was comparable (Table 3).
Procedural causes of GM. The following reasons were
responsible for the GM: 1) development of procedural
complications (additional stent implantation postradiation)
that extended the treatment beyond the margins of the
EIRS (52.8%, 57/108) (unexpected GM); 2) the INS from
prior inflations was not appropriately covered by the source
(34.2%, 37/108), termed as lack of accurate matching; and
3) treatment of long lesions requiring balloons or stents
longer than 26 mm (EIRS) and lack of availability of longer
(.30 mm) radiation source (13%, 14/108).
Restenosis rate. Follow-up angiograms were available in
115 out of 131 vessels. The restenosis rate in the EIRS was
23.5%. The presence or absence of GM did not affect the
incidence of restenosis in the EIRS (24.3% and 21.6%
respectively, p 5 0.8). The restenosis in the proximal edge
was 9.5% and in the distal edge 8.7%. Because binary
restenosis can be encountered more than once per VS
(either in the EIRS or at the edges) the summation of the
regional restenosis rate is higher than the restenosis rate in
the VS. There were three vessels with restenosis in both the
EIRS and the proximal edge and four vessels with restenosis
in both EIRS and the distal edge. There were no cases with
restenosis in both edges.
Generalized estimation equation analysis, which was used to
account for within-patient effects, showed that the probability
for restenosis at the edges of the EIRS depended on the GM
(p 5 0.0039), but not on distal/proximal lesion location (p 5
0.6) or the device (balloon/stent) used (p 5 0.1).
Regional restenosis rate in relation to GM. In each of the
115 vessels (101 patients), the impact of GM on restenosis
was analyzed in both proximal and distal edge (230 edges).
Geographical miss significantly increased the incidence of
restenosis at the edges of the EIRS compared with lesions
without GM (4.35% vs. 16.3%, p 5 0.004). This effect was
observed both in the proximal (5.56% vs. 16.28%, p 5 0.05)
and distal (3.03% vs. 16.33%, p 5 0.02) edges and seems to
be more pronounced at the distal edge (OR 5 5.3)
compared with the proximal (OR 5 3.2). The OR and the
CI are presented in Figure 2.
Impact of GM on the restenosis rate in relation to the
type of injury. Out of the 230 interpretable edges, 84
(36.5%) were related with balloon angioplasty termed as
balloon edges (BE) and 146 (63.5%) with stent implanta-
tion termed as stent edges (SE). The incidence of GM at
the BE and the SE was comparable (33.4% and 43.8%,
respectively). At the SE, GM increased the incidence of
restenosis significantly compared with edges without GM
(3.66% vs. 18.75%, p 5 0.006). At the BE, GM did not
significantly increase the incidence of restenosis (5.36% vs.
10.71%, p 5 0.35). The OR and the CI are presented in
Figure 3.
DISCUSSION
This study reports on the incidence and causes of GM and
its implications on edge restenosis in vessels treated with
intracoronary beta-radiation according to the BRIE proto-
Table 2. Vessel Characteristics in Relation to GM
Noninterpretable vessels 25.1% (44/175)
Interpretable vessels 74.9% (131/175)
Noninjured vessels 32.1% (42/131)
GM vessels 67.9% (89/131)
Vessels with GM proximal only 37% (33/89)
Vessels with GM distal only 41.5% (37/89)
Vessels with GM both proximal and distal 21.5% (19/89)
GM 5 geographical miss.
Table 3. Edge Characteristics in Relation to GM
Noninterpretable edges 25.1% (88/350)
Interpretable edges 74.9% (262/350)
Noninjured edges 58.8% (154/262)
GM edges 41.2% (108/262)
Proximal GM edges 48.2% (52/108)
Distal GM edges 51.8% (56/108)
GM 5 geographical miss.
Figure 2. Difference in the restenosis rate in the proximal distal and both
edges of the effective irradiated segment between geographical miss (GM)
and noninjured edges. White bars 5 no GM; black bars 5 GM. CI 5
confidence interval; OR 5 odds ratio.
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col. By careful retrospective angiographic analysis of all
vessels treated with the same radiation system, we defined
the effect of the injury on those areas located at the margins
of the source where the delivered dose was potentially rather
low.
Dosimetric zones. In any given vessel undergoing an
intervention followed by radiotherapy there are six possible
combinations of injury and irradiation: 1) segments injured
and fully irradiated (received the prescribed dose), repre-
senting the ideal treatment; 2) segments injured and receiv-
ing less than the prescribed dose defined as GM segments;
3) segments injured and receiving no dose (falling into the
category of conventional interventions); 4) segments non-
injured and receiving a full dose; 5) segments noninjured
and receiving a low dose, which represents a well-applied
treatment because there is no indication of any adverse
impact from low-dose radiation without injury after either
beta (15) or gamma radiation (21); and 6) segments non-
injured and receiving no radiation, falling into the category
of natural progression of atherosclerosis.
Geographical miss occurred in 67.9% of the vessels and
41.2% of edges analyzed. This concept requires the concur-
rence of two conditions: low-dose radiation and injury. It is
a dose-related term rather than an anatomical one. Injury
outside the field of radiation or low-dose irradiation of
noninjured tissue cannot be termed GM.
Stimulatory effect of low-dose radiation. The stimulatory
effect of low-dose radiation on smooth muscle cell prolifer-
ation has been previously reported in a swine coronary
balloon overstretch injury model (11). In the low-dose
radiation group (10 Gy), neointima was composed of
smooth muscle cells with a marked increase in inflammatory
cells and less medial and intimal fibrosis as compared with
higher dose groups (15 and 20 Gy) and the control group.
Similarly, after low-activity radioactive stent implantation
(1.0 mCi) in a porcine model, neointimal hyperplasia was
significantly greater than that after nonradioactive stenting
(12). Our group reported a late loss in injured edges treated
with the same system that was higher than that demon-
strated in the noninjured edges (14) and in previous studies
after balloon angioplasty or stent implantation (22,23). In a
three-dimensional volumetric intravascular ultrasound
(IVUS) investigation, our group again observed a decrease
in lumen volume at the edges because of an increase in
plaque volume not accommodated by vessel enlargement
(7). In patients receiving 6 to 12 mCi 32P radioactive stents,
where GM systematically occurs because of the current
balloon technology (6), 50% edge restenosis was reported
compared with 0% in-stent (5).
Proximal versus distal. Geographical miss increased re-
stenosis in both edges of the EIRS. This effect seems to be
more prominent at the distal edge compared with the
proximal. The smaller lumen distally attributable to normal
tapering of the vessels and the even less effectively irradiated
proximal edge because of its larger diameter may also be the
cause. Comparing the values of restenosis proximal and
distal at the GM edges, we can see that they are identical in
the range of 16.3%. What makes the OR higher for the
distal edge is the increased incidence of restenosis in the
noninjured proximal edges. Our group has reported this
through analysis of the noninjured edges of irradiated
segments by three-dimensional IVUS. Greater increase in
the plaque volume in the proximal edges compared with the
distal (27% vs. 9.2%, respectively) was reported (15). Non-
measurable vessel injuries (guiding catheter guidewires)
were hypothesized as the cause. Rheological factors may
play an important role and careful shear stress analysis could
elucidate the cause of restenosis at the proximal edge (24).
Balloon versus stent injury in relation to GM. Geo-
graphical miss related to stent injury is more prominently
associated with edge restenosis than is GM related to
balloon injury. The mechanisms involved in restenosis after
balloon angioplasty are different compared with these of
stenting. Negative remodeling and elastic recoil are the
causes of restenosis after balloon angioplasty, as opposed to
neointimal formation after stent implantation (25). Absence
of negative remodeling has been reported at the edges of the
irradiated segments after balloon angioplasty (14). This
might partly compensate for the stimulatory effect of radi-
ation on plaque growth at the balloon-injured GM edges,
making the combination less harmful.
The acute injury after stenting differs from that of the
coronary balloon angioplasty (8). The stent is a foreign body
and produces a permanent strain on the vessel wall, resulting
in a chronic injury and a prolonged stimulus for neointimal
formation (26). It is logical to conclude that the greater and
more prolonged the injury, the greater the impact on plaque
growth, and subsequently on restenosis, in conjunction with
low-dose radiation. In our study, significantly higher late
loss was observed in the irradiated segment in patients
treated with balloons compared with the stent-treated
patients (0.14 mm vs. 0.44 mm respectively, p 5 0.001).
This observation is in keeping with the other serious
adverse effects of the combination of stenting and radiation,
such as delayed stent thrombosis (27) and late stent mal-
apposition (28).
Figure 3. Difference in edge restenosis between geographical miss (GM)
edges associated with stent and balloon injury and noninjured edges. White
bars 5 no GM; black bars 5 GM. CI 5 confidence interval; OR 5 odds
ratio.
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Study limitations. This study is not placebo-controlled
and the effect of a sham source on injured coronary
segments has not been evaluated.
Only one type of radiation delivery catheter using the
beta-source 90Sr/90Y has been evaluated. Thus, the effect of
other systems using centering balloons and different sources
or gamma-radiotherapy on the GM edges cannot be extrap-
olated from our results.
Balloon inflation or stent implantation was considered
the only source of injury. Minor injuries from guiding
catheters, guidewires or radiation delivery catheters cannot
be completely ruled out.
Only binary restenosis data are quoted and the determi-
nation of GM is qualitative because there was no QCA
methodology available at the time to measure the length of
the GM.
Conclusions. Geographical miss is strongly correlated with
the development of restenosis at the edges of the EIRS. This
is a local phenomenon with a specific pathophysiology (com-
bination of injury and low-dose radiation) and is different from
the restenosis observed in the EIRS. This effect was observed
in both edges of the EIRS and seems to be more pronounced
at the distal edge compared with the proximal. Geographical
miss related to stent injury is associated with higher edge
restenosis compared with GM related to balloon injury. Geo-
graphical miss did not increase the incidence of restenosis in
the EIRS. If GM can be eliminated, the results of intracoro-
nary beta-radiation will be improved.
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